Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy

Cell Stem Cell - United States
doi 10.1016/j.stem.2018.10.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Regulatory T Cells in Cancer Immunotherapy

Cell Research
Cell BiologyMolecular Biology
2016English

Regulatory T Cells in Cancer Immunotherapy

Current Opinion in Immunology
AllergyImmunology
2014English

Enhancing the Efficacy of Prostate Cancer Immunotherapy by Manipulating T-Cell Receptor Signaling in Order to Alter Peripheral Regulatory T-Cell Activity

2011English

IL15 and T-Cell Stemness in T-Cell-Based Cancer Immunotherapy

Cancer Research
Cancer ResearchOncology
2015English

Soluble Γc Receptor Attenuates Anti-Tumor Responses of CD8+ T Cells in T Cell Immunotherapy

International Journal of Cancer
Cancer ResearchOncology
2018English

Induced Pluripotent Stem (iPS) Cell–derived, Chimeric Antigen Receptor (CAR)-expressing T Cells for Immunotherapy

Science-Business eXchange
2013English

Enhancing Adoptive Cancer Immunotherapy With Vγ2Vδ2 T Cells Through Pulse Zoledronate Stimulation

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer

Cancer Research
Cancer ResearchOncology
2007English

A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy

Stem Cell Reports
BiochemistryGeneticsDevelopmental BiologyCell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy